Aurobindo Pharma Q4 net profit down 8.07% at Rs 802.16 cr
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
The company reported standalone net profit of Rs 802.16 crore for the quarter ended March 31, 2022 as compared to Rs 872.58 crore in the same period last year, registering a year-on-year decline of 8.07 per cent. Net revenue of the company declined substantially by 29.87 per cent at Rs 2,877.83 crore in January-March quarter of this fiscal as against Rs 4,103.61 crore in the corresponding period last year.
During January-March quarter, operating expenses dropped by 24.15 per cent to Rs 2,380.20 crore from Rs 3,138.00 crore in year ago period. Other Income grew by 54.58 per cent at Rs 413.37 crore versus (Mar'21 Rs 267.42 crore). Operating Profit slipped by 48.06 per cent to Rs 506.97 crore as against Rs 976.03 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 25.90 per cent in March quarter. Interest declined by 17.20 per cent y-o-y to Rs 4.91 crore, while Taxation decreased by 126.01 per cent at Rs -62.66 crore (Mar'21 Rs 240.87 crore).
